miR-448 targets IDO1 and regulates CD8⁺ T cell response in human colon cancer.

However, the expression of NCR1 was increased in IDO1 overexpression group, but the difference did not reach statistical significance (Fig. 3 a, right panel).

also in 111,027 other papers